ID

18111

Beschrijving

Phase II Study of Capecitabine and Weekly Docetaxel Followed by Capecitabine Maintenance for Patients With Metastatic Breast Carcinoma; ODM derived from: https://clinicaltrials.gov/show/NCT00225056

Link

https://clinicaltrials.gov/show/NCT00225056

Trefwoorden

Versies (1)
  1. 20-10-16 20-10-16 -
Geüploaded op

20 oktober 2016

DOI

Voor een aanvraag inloggen.

Licentie

Creative Commons BY 4.0
Model Commentaren :

Hier kunt u commentaar leveren op het model. U kunt de tekstballonnen bij de itemgroepen en items gebruiken om er specifiek commentaar op te geven.

Terug naar het model Commentaren
Itemgroep Commentaren voor :

Item Commentaren voor :

U moet ingelogd zijn om formulieren te downloaden. AUB inloggen of schrijf u gratis in.

Eligibility Metastatic Breast Cancer NCT00225056

Engels

Eligibility Metastatic Breast Cancer NCT00225056

1 Formulieren  
Inclusion Criteria
Beschrijving

Inclusion Criteria

Alias
UMLS CUI
C1512693
must have metastatic breast cancer
Beschrijving

Carcinoma breast stage IV

Datatype

boolean

Alias
UMLS CUI [1]
C0278488
must have cytologically or pathologically confirmed invasive ductal or lobular carcinoma
Beschrijving

Invasive Ductal Breast Carcinoma | Carcinoma, Lobular

Datatype

boolean

Alias
UMLS CUI [1]
C1134719
UMLS CUI [2]
C0206692
must have measurable or evaluable disease
Beschrijving

Measurable Disease | Evaluable Disease

Datatype

boolean

Alias
UMLS CUI [1]
C1513041
UMLS CUI [2]
C1516986
ecog of 0-1
Beschrijving

ECOG performance status

Datatype

boolean

Alias
UMLS CUI [1]
C1520224
patients may have received 0, 1. or 2 prior treatments for metastatic breast cancer
Beschrijving

Prior Therapy Quantity Carcinoma breast stage IV

Datatype

boolean

Alias
UMLS CUI [1,1]
C1514463
UMLS CUI [1,2]
C1265611
UMLS CUI [1,3]
C0278488
must have adequate organ function
Beschrijving

organ function

Datatype

boolean

Alias
UMLS CUI [1]
C0678852
must be at least 19 years of age
Beschrijving

Age

Datatype

boolean

Alias
UMLS CUI [1]
C0001779
peripheral neuropathy less than or equal to grade 1
Beschrijving

Peripheral Neuropathy | CTCAE Grades

Datatype

boolean

Alias
UMLS CUI [1]
C0031117
UMLS CUI [2]
C1516728
must have voluntarily signed informed consent
Beschrijving

Informed Consent

Datatype

boolean

Alias
UMLS CUI [1]
C0021430
patients with brain metastases are eligible provided that other measurable disease exists and brain lesions are controlled
Beschrijving

Metastatic malignant neoplasm to brain | Measurable Disease | Lesion of brain Controlled

Datatype

boolean

Alias
UMLS CUI [1]
C0220650
UMLS CUI [2]
C1513041
UMLS CUI [3,1]
C0221505
UMLS CUI [3,2]
C2911690
Exclusion Criteria
Beschrijving

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with other malignancies, except non melanoma of the skin, who have had any evidence of cancer within the last 5 years
Beschrijving

Malignant Neoplasms | Skin carcinoma

Datatype

boolean

Alias
UMLS CUI [1]
C0006826
UMLS CUI [2]
C0699893
patients with psychiatric illness or other concurrent severe co-morbid medical condition that would preclude study completion
Beschrijving

Mental disorder Excludes Clinical Trial Completion | Comorbidity Severe Excludes Clinical Trial Completion

Datatype

boolean

Alias
UMLS CUI [1,1]
C0004936
UMLS CUI [1,2]
C0332196
UMLS CUI [1,3]
C0008976
UMLS CUI [1,4]
C0205197
UMLS CUI [2,1]
C0009488
UMLS CUI [2,2]
C0205082
UMLS CUI [2,3]
C0332196
UMLS CUI [2,4]
C0008976
UMLS CUI [2,5]
C0205197
known uncontrolled existing coagulopathy
Beschrijving

Blood Coagulation Disorder Uncontrolled

Datatype

boolean

Alias
UMLS CUI [1,1]
C0005779
UMLS CUI [1,2]
C0205318
patients with a history of severe hypersensitivity reaction to docetaxel, medications formulated with polysorbate 80 or 5-fluorouracil
Beschrijving

severe allergy docetaxel | severe allergy Polysorbate 80 Formulation | severe allergy Fluorouracil Formulation

Datatype

boolean

Alias
UMLS CUI [1,1]
C2945656
UMLS CUI [1,2]
C0246415
UMLS CUI [2,1]
C2945656
UMLS CUI [2,2]
C0032601
UMLS CUI [2,3]
C1705957
UMLS CUI [3,1]
C2945656
UMLS CUI [3,2]
C0016360
UMLS CUI [3,3]
C1705957
use of other investigational agents in the last 28 days
Beschrijving

Investigational New Drugs

Datatype

boolean

Alias
UMLS CUI [1]
C0013230
pregnant or lactating women
Beschrijving

Pregnancy | Breast Feeding

Datatype

boolean

Alias
UMLS CUI [1]
C0032961
UMLS CUI [2]
C0006147
patients who are known hiv positive
Beschrijving

HIV Seropositivity

Datatype

boolean

Alias
UMLS CUI [1]
C0019699
patients with life expectancy of less than 3 months
Beschrijving

Life Expectancy

Datatype

boolean

Alias
UMLS CUI [1]
C0023671
sexually active patients unwilling to practice reliable contraception during the study
Beschrijving

Sex Behavior Contraceptive methods Unwilling

Datatype

boolean

Alias
UMLS CUI [1,1]
C0036864
UMLS CUI [1,2]
C0700589
UMLS CUI [1,3]
C0558080
Terug naar het begin van de pagina

Similar models

Eligibility Metastatic Breast Cancer NCT00225056

1 Formulieren
Name
Type
Description | Question | Decode (Coded Value)
Datatype
Alias
Item Group
C1512693 (UMLS CUI)
Carcinoma breast stage IV
Item
must have metastatic breast cancer
boolean
C0278488 (UMLS CUI [1])
Invasive Ductal Breast Carcinoma | Carcinoma, Lobular
Item
must have cytologically or pathologically confirmed invasive ductal or lobular carcinoma
boolean
C1134719 (UMLS CUI [1])
C0206692 (UMLS CUI [2])
Measurable Disease | Evaluable Disease
Item
must have measurable or evaluable disease
boolean
C1513041 (UMLS CUI [1])
C1516986 (UMLS CUI [2])
ECOG performance status
Item
ecog of 0-1
boolean
C1520224 (UMLS CUI [1])
Prior Therapy Quantity Carcinoma breast stage IV
Item
patients may have received 0, 1. or 2 prior treatments for metastatic breast cancer
boolean
C1514463 (UMLS CUI [1,1])
C1265611 (UMLS CUI [1,2])
C0278488 (UMLS CUI [1,3])
organ function
Item
must have adequate organ function
boolean
C0678852 (UMLS CUI [1])
Age
Item
must be at least 19 years of age
boolean
C0001779 (UMLS CUI [1])
Peripheral Neuropathy | CTCAE Grades
Item
peripheral neuropathy less than or equal to grade 1
boolean
C0031117 (UMLS CUI [1])
C1516728 (UMLS CUI [2])
Informed Consent
Item
must have voluntarily signed informed consent
boolean
C0021430 (UMLS CUI [1])
Metastatic malignant neoplasm to brain | Measurable Disease | Lesion of brain Controlled
Item
patients with brain metastases are eligible provided that other measurable disease exists and brain lesions are controlled
boolean
C0220650 (UMLS CUI [1])
C1513041 (UMLS CUI [2])
C0221505 (UMLS CUI [3,1])
C2911690 (UMLS CUI [3,2])
Item Group
C0680251 (UMLS CUI)
Malignant Neoplasms | Skin carcinoma
Item
patients with other malignancies, except non melanoma of the skin, who have had any evidence of cancer within the last 5 years
boolean
C0006826 (UMLS CUI [1])
C0699893 (UMLS CUI [2])
Mental disorder Excludes Clinical Trial Completion | Comorbidity Severe Excludes Clinical Trial Completion
Item
patients with psychiatric illness or other concurrent severe co-morbid medical condition that would preclude study completion
boolean
C0004936 (UMLS CUI [1,1])
C0332196 (UMLS CUI [1,2])
C0008976 (UMLS CUI [1,3])
C0205197 (UMLS CUI [1,4])
C0009488 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
C0332196 (UMLS CUI [2,3])
C0008976 (UMLS CUI [2,4])
C0205197 (UMLS CUI [2,5])
Blood Coagulation Disorder Uncontrolled
Item
known uncontrolled existing coagulopathy
boolean
C0005779 (UMLS CUI [1,1])
C0205318 (UMLS CUI [1,2])
severe allergy docetaxel | severe allergy Polysorbate 80 Formulation | severe allergy Fluorouracil Formulation
Item
patients with a history of severe hypersensitivity reaction to docetaxel, medications formulated with polysorbate 80 or 5-fluorouracil
boolean
C2945656 (UMLS CUI [1,1])
C0246415 (UMLS CUI [1,2])
C2945656 (UMLS CUI [2,1])
C0032601 (UMLS CUI [2,2])
C1705957 (UMLS CUI [2,3])
C2945656 (UMLS CUI [3,1])
C0016360 (UMLS CUI [3,2])
C1705957 (UMLS CUI [3,3])
Investigational New Drugs
Item
use of other investigational agents in the last 28 days
boolean
C0013230 (UMLS CUI [1])
Pregnancy | Breast Feeding
Item
pregnant or lactating women
boolean
C0032961 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
HIV Seropositivity
Item
patients who are known hiv positive
boolean
C0019699 (UMLS CUI [1])
Life Expectancy
Item
patients with life expectancy of less than 3 months
boolean
C0023671 (UMLS CUI [1])
Sex Behavior Contraceptive methods Unwilling
Item
sexually active patients unwilling to practice reliable contraception during the study
boolean
C0036864 (UMLS CUI [1,1])
C0700589 (UMLS CUI [1,2])
C0558080 (UMLS CUI [1,3])
Terug naar het begin van de pagina 

Contact

Gebruik dit formulier voor feedback, vragen en verbeteringsvoorstellen.

Velden gemarkeerd met een * zijn verplicht.

Help

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial